Last updated on November 2017

A study to evaluate the efficacy and safety of E2609 in individuals with early Alzheimer's disease

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Memory Loss | Alzheimer's Disease
  • Age: Between 55 - 85 Years
  • Gender: Male or Female

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.